These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 373958)

  • 1. A framework for the quality assurance of clinical data.
    Williams OD
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):700-2. PubMed ID: 373958
    [No Abstract]   [Full Text] [Related]  

  • 2. External monitoring in multiclinic trials: applications from ophthalmologic studies.
    Ferris FL; Ederer F
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):720-3. PubMed ID: 373962
    [No Abstract]   [Full Text] [Related]  

  • 3. Quality assurance of clinical data: invited remarks.
    Silvers A
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):725. PubMed ID: 373964
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality assurance of clinical data: internal monitoring: patient and study management at the clinic.
    Evans JT
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):712-6. PubMed ID: 373960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspects of clinic monitoring in large-scale multiclinic trials.
    Mowery RL; Williams OD
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):717-9. PubMed ID: 373961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assurance of clinical data: diagnostic standardization.
    Kahn HA
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):703-11. PubMed ID: 373959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance of clinical data: invited remarks. Remarks on quality enhancement in SENIC.
    Lachenbruch PA
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):724. PubMed ID: 373963
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings of the National Conference on Clinical Trials Methodology.
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):629-766. PubMed ID: 35299
    [No Abstract]   [Full Text] [Related]  

  • 9. Communications: Should mechanisms be established for sharing among clinical trial investigators experiences in handling problems in design, execution, and analysis? Problems of omission in communications.
    Mosteller F
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):761-4. PubMed ID: 373970
    [No Abstract]   [Full Text] [Related]  

  • 10. Communications: Should mechanisms be established for sharing among clinical trial investigators experiences in handling problems in design, execution, and analysis? Methodology: the case for improved communications.
    Meinert CL; Hawkins BS
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):754-7. PubMed ID: 373968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical biostatistics. XLV. The purposes and functions of criteria.
    Feinstein AR
    Clin Pharmacol Ther; 1978 Oct; 24(4):779-92. PubMed ID: 688738
    [No Abstract]   [Full Text] [Related]  

  • 12. When and how to stop a clinical trial: introduction.
    Meinert CL
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):632. PubMed ID: 373944
    [No Abstract]   [Full Text] [Related]  

  • 13. Logistics and management of clinical trials.
    Greenberg G
    Br J Clin Pharmacol; 1982 Jul; 14(1):25-30. PubMed ID: 7104166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When and how to stop a clinical trial: invited remarks.
    Hamilton MT
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):647-8. PubMed ID: 373947
    [No Abstract]   [Full Text] [Related]  

  • 15. When and how to stop a clinical trial: invited remarks.
    Chalmers TC
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):649-50. PubMed ID: 373948
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving the design of your evaluation process.
    Cooper LG
    Crossreference; 1975 Dec; 5(11):3-4. PubMed ID: 10237320
    [No Abstract]   [Full Text] [Related]  

  • 17. When and how to stop a clinical trial: invited remarks.
    Stamler J
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):651-4. PubMed ID: 373949
    [No Abstract]   [Full Text] [Related]  

  • 18. Effective clinical trials investigators and adequate incentives.
    Stamler J
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):666-70. PubMed ID: 373951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrieving information on clinical methodology.
    Schoolman HM
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 2):758-60. PubMed ID: 373969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance operations: good clinical practices.
    Castellion AW
    Drug Inf J; 1983; 17(1):25-9. PubMed ID: 10262248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.